Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Colistin for MDR Ventilator-Associated Pneumonia in Stroke Patients
NCT07865871Phase 1Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Oct 2026
- Primary completion
- Oct 2027
01
Overview
Phase 1, randomised trial of colistin in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Ain Shams University. Primary endpoint: Clinical response at 2 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
colistin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT07865871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07865871.